Higher HbA1c levels and longer duration of Diabetes increase HF risk among Diabetics Dr.Niharika Harsha B30 Nov 2022 9:00 AM ISTNew research found that there is an increased risk of heart failure among diabetic patients who have had diabetes for a long duration and increased...
Hepatic Safety Profile of Vildagliptin 100 mg SR - Ft. Prof. Dr Aravinda Jagadeesha Dr. Nandita Mohan26 Nov 2022 12:33 PM IST Vildagliptin has established its efficacy over the years by displaying significant HbA1c lowering accompanied by body weight-neutral and...
Long Term exposure to high-intensity outdoor light at night linked to Diabetes Prevalence Dr.Niharika Harsha B18 Nov 2022 10:30 AM ISTResearchers from China found that chronic exposure to higher-intensity outdoor Light at night (LAN) increases the prevalence of Diabetes due to an...
Do digital behavioral therapeutic applications effectively lower HbA1c? Study offers insight Dr. Kamal Kant Kohli16 Nov 2022 8:00 PM ISTU.S.A.: According to research from a randomized controlled study that was published in Diabetes Care, cognitive behavioral therapy (CBT) delivered...
Lowering HbA1C Levels To Less Than 7% Increases Life Expectancy In Diabetics By 3.8 Years Dr. Nithin Reddy Modhugu14 Nov 2022 12:45 PM ISTThe advantages of better glycemic management on diabetes patients' quality-adjusted life years have long been understood. It is also well-accepted...
HbA1c control linked to recovery of ejection fraction in hospitalized HF patients with diabetes Medha Baranwal13 Nov 2022 8:00 PM ISTResearchers have found in a new study that glycemic control was associated with recovery of ejection fraction among hospitalized patients of...
High blood sugar levels may worsen course and prognosis of COPD regardless of diabetes status Dr. Kamal Kant Kohli6 Nov 2022 10:15 PM ISTCHINA: Chronic obstructive pulmonary disease (COPD) characterized by progressive partially reversible airflow obstruction and airways inflammation is...
Adherence to low carbohydrate diet reduces blood sugar and HbA1c in Prediabetics: JAMA Dr. Kamal Kant Kohli31 Oct 2022 10:15 AM ISTLouisiana: Researchers at Tulane University have found in a randomized clinical trial that sticking to a low-carbohydrate diet helped people with...
SGLT2 inhibitors and GLP1 receptor antagonists effectively control blood sugar but are prohibitively expensive Dr. Kamal Kant Kohli13 Oct 2022 7:30 PM ISTSGLT2 and GLP1 have been found to reduce atherosclerotic cardiovascular disease (ASCVD), microvascular disease, and mortality in addition to improving...
Intermittent CGM monitoring tied to higher HbA1c reduction compared to finger stick testing in T1 diabetes: NEJM Dr. Kamal Kant Kohli8 Oct 2022 10:30 AM ISTU.K. : According to study results published in The New England Journal of Medicine, intermittently scanned continuous glucose monitoring use is linked...
Tirzepatide achieves blood sugar control and weight-loss goals faster than existing diabetes drugs Dr. Kamal Kant Kohli16 Sept 2022 8:00 PM ISTTirzepatide lowers blood sugar and supports weight loss better than other drugs for type 2 diabetes (T2D) was established by in phase 3 SURPASS trials...
Advanced hybrid closed therapy improves blood sugar control in patients with type 1 diabetes: Lancet Dr. Kamal Kant Kohli6 Sept 2022 9:00 AM ISTGermany: Glycemic control in people with type 1 diabetes is improved by using Medtronic MiniMed 780G system, an advanced hybrid closed therapy...
